90 results
8-K
EX-10.2
PMCB
PharmaCyte Biotech Inc
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.4
PMCB
PharmaCyte Biotech Inc
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.3
PMCB
PharmaCyte Biotech Inc
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.1
PMCB
PharmaCyte Biotech Inc
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.3
PMCB
PharmaCyte Biotech Inc
11 May 23
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
8:30am
8-K
EX-10.1
5wx6i
11 May 23
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
8:30am
8-K
EX-10.2
i9kw8ux2a i6olr
11 May 23
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
8:30am
8-K
EX-10.1
ww3fqc1s6 zadw49jqx
14 Oct 22
Departure of Directors or Certain Officers
4:12pm
8-K
EX-10.1
833 9uxlzup
7 Oct 22
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
4:53pm
8-K
EX-10.1
l0cs6 f1k0lnlh4qz1pr
15 Aug 22
Company Appoints Five New Independent Directors to Reconstituted Board
6:55pm
8-K
EX-10.2
cxhco9gcueh
15 Aug 22
Company Appoints Five New Independent Directors to Reconstituted Board
6:55pm
DEFA14A
EX-10.2
3ky eb6m721om
15 Aug 22
Additional proxy soliciting materials
6:53pm
DEFA14A
EX-10.1
2i56ik l7f
15 Aug 22
Additional proxy soliciting materials
6:53pm
8-K
EX-10.1
i7dqoa026ay8f
23 Aug 21
PharmaCyte Biotech Announces $70 Million Registered Direct Offering
6:01am
8-K
EX-10.1
tax85r mh
16 Oct 20
Departure of Directors or Certain Officers
4:57pm